1. Academic Validation
  2. Regulating NCOA4-Mediated Ferritinophagy for Therapeutic Intervention in Cerebral Ischemia-Reperfusion Injury

Regulating NCOA4-Mediated Ferritinophagy for Therapeutic Intervention in Cerebral Ischemia-Reperfusion Injury

  • Neurochem Res. 2024 Jul;49(7):1806-1822. doi: 10.1007/s11064-024-04146-4.
Lan Zhao # 1 Yanan Li # 2 Wei Wang 2 Xue Qi 2 Su Wang 2 Wenqin Song 2 Ting Li 3 Wenwei Gao 4
Affiliations

Affiliations

  • 1 Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • 2 Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • 3 Department of Skin Medical Cosmetology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. liting1102@126.com.
  • 4 Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China. wenwei_gao@163.com.
  • # Contributed equally.
Abstract

Ischemic stroke presents a global health challenge, necessitating an in-depth comprehension of its pathophysiology and therapeutic strategies. While reperfusion therapy salvages brain tissue, it also triggers detrimental cerebral ischemia-reperfusion injury (CIRI). In our investigation, we observed the activation of nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy in an oxygen-glucose deprivation/reoxygenation (OGD/R) model using HT22 cells (P < 0.05). This activation contributed to oxidative stress (P < 0.05), enhanced Autophagy (P < 0.05) and cell death (P < 0.05) during CIRI. Silencing NCOA4 effectively mitigated OGD/R-induced damage (P < 0.05). These findings suggested that targeting NCOA4-mediated ferritinophagy held promise for preventing and treating CIRI. Subsequently, we substantiated the Cyclic GMP-AMP Synthase (cGAS)-stimulator of interferon genes (STING) pathway effectively regulated the NCOA4-mediated ferritinophagy, by applying the cGAS inhibitor RU.521 and performing NCOA4 overexpression (P < 0.05). Suppressing the cGAS-STING pathway efficiently curtailed ferritinophagy (P < 0.05), oxidative stress (P < 0.05), and cell damage (P < 0.05) of CIRI, while NCOA4 overexpression could alleviate this effect (P < 0.05). Finally, we elucidated the specific molecular mechanism underlying the protective effect of the iron chelator deferoxamine (DFO) on CIRI. Our findings revealed that DFO alleviated hypoxia-reoxygenation injury in HT22 cells through inhibiting NCOA4-mediated ferritinophagy and reducing ferrous ion levels (P < 0.05). However, the protective effects of DFO were counteracted by cGAS overexpression (P < 0.05). In summary, our results indicated that the activation of the cGAS-STING pathway intensified cerebral damage during CIRI by inducing NCOA4-mediated ferritinophagy. Administering the iron chelator DFO effectively attenuated NCOA4-induced ferritinophagy, thereby alleviating CIRI. Nevertheless, the role of the cGAS-STING pathway in CIRI regulation likely involves intricate mechanisms, necessitating further validation in subsequent investigations.

Keywords

Autophage; Ferritinophagy; Iron; NCOA4; OGD/R; Oxidative stress; cGAS-STING.

Figures
Products